Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

10. Long-Term Debt (Tables)

12 Months Ended

Mar. 31, 2017

For Years Ending March 31,
	2018	$	127,000
	2019		13,000
	2020		13,000
	2021		13,000
	2022		6,000
	Total minimum payments	$	172,000
	Less: amounts representing interest		(4,000	)
	Present value of payments		168,000
	Less: current portion		(123,000	)
	Long-term portion	$	45,000